| T H E R A P E U T I C S |
| E R A D I C A T I N G H E A R I N G L O S S G L O B A L L Y |
Audigen's scientific team is uniquely qualified to research and commercialize inner ear-
oriented medical break-throughs.
Dr. George S. Robertson, Ph.D. (Professor and chair, Psychiatry and Pharmacology,
Dalhousie University, Nova Scotia) is a world leading authority on the therapeutic
potential of XIAP for the treatment of neurodegenerative disorders. Dr. Robertson has
industrial expertise as Head of Department of Pharmacology, Merck Frosst Centre for
Therapeutic Research, Quebec, Canada, 1998-2002.
Dr. Manohar Bance (Professor and chair, Otolaryngology, Dalhousie University, Nova
Scotia, MB, MSc, FRCS(C)) is a world renowned ear surgeon and clinician-scientist. He
has been extensively involved in hearing loss, cochlear implants, other auditory
implants, balance disorders, and developing rehabilitation technologies for the inner ear
and age-related hearing loss.
Dr. Jian Wang, Ph.D. (Professor of Human Communication Disorder, Dalhousie
University, Nova Scotia, and guest professor in Otorhinolaryngology at Jiao-Tong
University, Shanghai) has been investigating hearing disorders for more than 20 years
and has a leading international reputation for the development of gene therapy
approaches for the treatment of disorders of the inner ear (XIAP-based gene therapy).
William W. Hauswirth, Ph.D. (Rybaczki-Bullard Professor of Ophthalmology and
Molecular Genetics, University of Florida College of Medicine) is considered to be the
world’s foremost authority on adeno-associated virus gene therapy. He has authored over
220 articles and his pioneering work in AAV mediated gene therapy was ranked as the
third most important scientific discovery of 2009 by Time Magazine.
oriented medical break-throughs.
Dr. George S. Robertson, Ph.D. (Professor and chair, Psychiatry and Pharmacology,
Dalhousie University, Nova Scotia) is a world leading authority on the therapeutic
potential of XIAP for the treatment of neurodegenerative disorders. Dr. Robertson has
industrial expertise as Head of Department of Pharmacology, Merck Frosst Centre for
Therapeutic Research, Quebec, Canada, 1998-2002.
Dr. Manohar Bance (Professor and chair, Otolaryngology, Dalhousie University, Nova
Scotia, MB, MSc, FRCS(C)) is a world renowned ear surgeon and clinician-scientist. He
has been extensively involved in hearing loss, cochlear implants, other auditory
implants, balance disorders, and developing rehabilitation technologies for the inner ear
and age-related hearing loss.
Dr. Jian Wang, Ph.D. (Professor of Human Communication Disorder, Dalhousie
University, Nova Scotia, and guest professor in Otorhinolaryngology at Jiao-Tong
University, Shanghai) has been investigating hearing disorders for more than 20 years
and has a leading international reputation for the development of gene therapy
approaches for the treatment of disorders of the inner ear (XIAP-based gene therapy).
William W. Hauswirth, Ph.D. (Rybaczki-Bullard Professor of Ophthalmology and
Molecular Genetics, University of Florida College of Medicine) is considered to be the
world’s foremost authority on adeno-associated virus gene therapy. He has authored over
220 articles and his pioneering work in AAV mediated gene therapy was ranked as the
third most important scientific discovery of 2009 by Time Magazine.
| Copyright © 2011, Audigen, Inc. All Rights Reserved. |
 |  |  |  |
| ... |